PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25795461-2	2015	In the present study, we show that this ERalpha-mediated upregulation was significantly reduced by two ER antagonists (fulvestrant and raloxifene) but was not affected by a third ER antagonist, 4-hydroxytamoxifen (4-OHTAM), a major active tamoxifen (TAM) metabolite.	Raloxifene Hydrochloride	135-145	estrogen receptor 1	Homo sapiens	40-47